Oral vitamin D3 5000 IU/day as an adjuvant in the treatment of atopic dermatitis: a randomized control trial

ConclusionsReaching serum levels of 25(OH)D>  20 ng/ml in conjunction with standard therapy is sufficient to achieve a reduction in severity (SCORAD) in patients with AD.

Source: International Journal of Dermatology - November 9, 2018 Category: Dermatology Authors: Karen S ánchez‐Armendáriz, Ana García‐Gil, Cesar A. Romero, José Contreras‐Ruiz, Marcia Karam‐Orante, Denek Balcazar‐Antonio, Judith Domínguez‐Cherit Tags: Clinical Trial Source Type: research